In addition to supporting a potential use of TRPM8 in anti-tumor therapy as a dual target to simultaneously counteract metastatic dissemination and angiogenesis, they also shed new light on the possibility of using TRP channels as targets for the development of peptidomimetics in cancer therapy. The gene discussed is TRPM8; the disease is neoplasm.